Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 12:00 PM CET
Settings

Settings

Goto Application

1. WO2022011157 - USE OF 2'-FL FOR TREATMENT OF SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER

Publication Number WO/2022/011157
Publication Date 13.01.2022
International Application No. PCT/US2021/040915
International Filing Date 08.07.2021
IPC
A23L 33/00 2016.1
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
A61K 31/702 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A61P 1/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 25/28 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
A61P 37/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37Drugs for immunological or allergic disorders
Applicants
  • GLYCOSYN LLC [US]/[US]
Inventors
  • MORROW, Ardythe L.
  • ALBERTS, Jeffrey
Agents
  • BEATTIE, Ingrid A.
  • ALLISON, William, F.
  • ADAMS, Lisa
  • AMENDT, Kevin, C.
  • AZRIN, Linda, B.
Priority Data
63/049,50308.07.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) USE OF 2'-FL FOR TREATMENT OF SYMPTOMS ASSOCIATED WITH AUTISM SPECTRUM DISORDER
(FR) UTILISATION DE 2'-FL POUR LE TRAITEMENT DE SYMPTÔMES ASSOCIÉS À UN TROUBLE DU SPECTRE AUTISTIQUE
Abstract
(EN) Provided herein are compositions and methods for reducing a symptom autism spectrum disorder in a subject such as a human infant or child. The method involves administering to the subject a composition comprising purified 2'-fucosyllactose.
(FR) L'invention concerne des compositions et des méthodes pour réduire un symptôme d'un trouble du spectre autistique chez un sujet tel qu'un nourrisson ou un enfant. La méthode consiste à administrer au sujet une composition comprenant le 2'-fucosyllactose purifié.
Latest bibliographic data on file with the International Bureau